Related Experiment Videos
Growth factor delivery for bone tissue repair: an update.
Mathew Varkey1, Sebastien A Gittens, Hasan Uludag
1University of Alberta, Department of Chemical & Materials Engineering, Faculty of Engineering, 526 Chemical and Materials Engineering Building, Edmonton, Alberta T6G 2G6, Canada.
Expert Opinion on Drug Delivery
|November 22, 2005
Summary
Growth factors (GFs) show promise for bone repair, with approved therapies for local repair and systemic bone mass augmentation. Research explores biomaterials for GF delivery and gene-based approaches for enhanced bone regeneration.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Orthopedics
Background:
- Growth factors (GFs) are proteins crucial for bone regeneration.
- Clinical applications for bone repair and augmentation are emerging.
- Recent approvals include bone morphogenetic protein-2, osteogenic protein-1, and human parathyroid hormone (1-34).
Purpose of the Study:
- To review recent (2001-2004) strategies for growth factor delivery in bone tissue regeneration.
- To summarize findings from non-human primate and rodent studies.
- To discuss future research directions for clinical GF application.
Main Methods:
- Review of non-human primate studies on local bone regeneration using various biomaterials for GF delivery.
- Summary of GFs administered for systemic bone tissue augmentation.
- Analysis of gene delivery methods for osteogenic proteins in rodent models.
Main Results:
- Biomaterials play a key role in local GF delivery for bone repair.
- Systemic GF administration shows potential for bone mass augmentation.
- Gene delivery offers an alternative to protein delivery for bone regeneration.
Conclusions:
- Growth factors hold significant potential for clinical bone repair and regeneration.
- Optimizing delivery systems and exploring gene-based approaches are crucial for future advancements.
- Continued research is needed to enhance the clinical translation of GF therapies.